Clinical Trials Directory

Trials / Completed

CompletedNCT03531385

Assessment of Central Sensitization, Neuropathic Pain, Sleep Quality and Daily Life Activities in Behcet's Disease

Assessment of Central Sensitization, Neuropathic Pain, Sleep Quality and Daily Life Activities in Behcet's Disease and Healthy Controls

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Bursa Yuksek Ihtisas Training and Research Hospital · Other Government
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

There are few studies in the literature regarding increased frequency of neuropathic pain and sleep disturbance and decreased quality of life in Behçet's disease. Frequency of central sensitization was not investigated in patients with Behçet's disease before. In this study, it is aimed to investigate the frequency of central sensitization, neuropathic pain, sleep disorder and quality of life and their relation to each other in Behcet's disease.

Detailed description

Central sensitization reduces the pain threshold in the pain pathways of the nervous system, causing pain sensation to be perceived with lower stimuli and often causing chronic pain. Central sensitization can be seen with many conditions such as neuropathic pain and sleep disorders, as well as with inflammatory diseases such as rheumatoid arthritis. There are few studies in the literature regarding increased frequency of neuropathic pain and sleep disturbance and decreased quality of life in Behçet's disease. Frequency of central sensitization was not investigated in patients with Behçet's disease before. In this study, it is aimed to investigate the frequency of central sensitization, neuropathic pain, sleep disorder and quality of life and their relation to each other in patients with Behcet's disease and healthy controls.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCentral sensitisationCentral Sensitization Inventory, which is a comprehensive self-report inventory to assess the overlapping symptom dimensions of central sensitisation syndrome will be used to identify participants with central sensitisation.
DIAGNOSTIC_TESTNeuropathic painFrequency of neuropatic pain will be investigated using Pain Detect Questionnaire
OTHERSleep disturbanceAssessment of sleep disturbance will be assessed by Pittsburgh Sleep Quality Index
OTHERQuality of lifeQuality of life will be assessed by the Nottingham Health Profile

Timeline

Start date
2018-05-22
Primary completion
2019-02-01
Completion
2019-03-21
First posted
2018-05-21
Last updated
2019-07-11

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03531385. Inclusion in this directory is not an endorsement.